UBS lifts MetLife price target to USD 110
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
UBS raised its MetLife price target to USD 110 from USD 105 while keeping a Buy rating, after the insurer posted second-quarter 2026 adjusted earnings of USD 1.57 billion, up 15% year over year. MetLife also reported a 17% adjusted return on equity and declared a quarterly dividend of USD 0.5925 per share.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.